Proudly Based in Canada | Premium Research Peptides for Modern Science
Understanding Peptide Purity, Identity, COAs, HPLC and Mass Spectrometry
Research Overview
Before a peptide is used in any experiment, there is a basic question that has to be answered first: what exactly is in the vial? A label can tell us what a sample is supposed to be, but research requires more than a label. Researchers need evidence that the material actually contains the intended peptide, that the sample has been characterized appropriately, and that the analytical information supplied with it is strong enough to support the work that follows.
This is where terms such as identity, purity, assay, impurity profile, Certificate of Analysis, HPLC, and mass spectrometry begin to matter. They are often presented together, but they do not mean the same thing. Identity asks whether the correct peptide is present. Purity asks how much of the detected peptide-related material appears to be the desired molecule rather than other components. Assay or content asks how much of the target peptide is actually present. Impurity profiling asks what else may be in the sample and, where possible, what those other components are.
These distinctions are important because a sample can perform well in one analytical test while still leaving other questions unanswered. A peptide might show a very strong main peak on an HPLC chromatogram, for example, but that result alone does not prove the exact molecular identity of the peak. Likewise, mass spectrometry might show a molecular mass consistent with the expected peptide while saying relatively little about how much of the overall sample is made up of minor related impurities.
Regulatory analytical guidance treats these as separate analytical purposes rather than interchangeable terms. The International Council for Harmonisation, or ICH, specifically distinguishes identification, assay, purity, and impurity testing and emphasizes that an analytical procedure should be appropriate for the question it is intended to answer.
The most useful way to approach peptide analysis is therefore not to search for one “perfect” number. It is to build a body of evidence. A well-characterized sample is one in which several pieces of information point toward the same conclusion.
The Big Picture
A useful analogy is to imagine identifying a person at a secure border crossing. A name on a piece of paper provides very little confidence. A passport provides more. A photograph adds another layer. A fingerprint provides a different kind of confirmation again. None of those checks is identical, but together they create much stronger confidence in who that person is.
Peptide characterization works in much the same way.
A Certificate of Analysis, or COA, summarizes what was tested and what the laboratory reported. HPLC helps show how the sample separates into major and minor components. Mass spectrometry can provide strong evidence that the molecular mass of the material matches what is expected. Tandem mass spectrometry can go further by examining fragments of the peptide and providing additional sequence-related information.
Other analytical methods may also be used depending on the purpose of the testing and the characteristics of the peptide. These can include nuclear magnetic resonance, amino acid analysis, chiral testing, water determination, residual-solvent testing, counterion analysis, and other techniques.
This is why analytical scientists often talk about orthogonal methods. An orthogonal method is simply a different way of looking at the same sample. When two methods rely on different scientific principles yet support the same conclusion, confidence increases.
That becomes especially important with peptides because many peptide impurities can look chemically very similar to the target molecule.
A peptide is built from amino acids arranged in a particular sequence. During synthesis, several types of related impurities can be produced. One amino acid may be missing, producing a deletion sequence. An extra amino acid may be inserted. A chain may stop too early, producing a truncated peptide. A residue may be incorporated incorrectly, or the peptide may undergo chemical changes after synthesis.
Peptides can also change over time. Depending on the peptide and its environment, degradation can involve oxidation, deamidation, isomerization, hydrolysis, aggregation, or other chemical changes. Some of those altered molecules may behave almost like the target peptide, which means a simple analytical method may not always separate them perfectly.
This leads to one of the most important ideas in the entire article:
A test result is only as informative as the method’s ability to detect what you are looking for.
A chromatogram that looks clean is useful evidence, but it is not proof that every possible impurity has been ruled out. A mass result that matches expectations is strong identity evidence, but it does not automatically establish complete purity. The strength comes from combining the information.
How It Works
A Certificate of Analysis is usually the first document a researcher encounters. At its simplest, the COA is a summary of testing performed on a particular sample or lot. A useful report should clearly identify the material, connect the results to a particular batch, explain what was tested, state the methods used, and report the analytical results in a way that can be understood.
That distinction is worth emphasizing: the COA itself is not the analytical test. It is the report summarizing the test.
Two COAs may therefore look equally professional while containing very different levels of scientific information. One may provide only a peptide name and a statement such as “Purity: 99%.” Another may include the lot number, test date, HPLC method, chromatogram, expected molecular mass, observed molecular mass, mass spectrum, analyst information, specifications, and additional testing.
The second document allows the reader to evaluate much more of the analytical story.
One of the most common misunderstandings involves the phrase “99% purity by HPLC.” It is tempting to interpret that statement as meaning that 99% of everything physically present in the vial is the desired peptide. That is not necessarily what the result means.
In many HPLC purity methods, the percentage is based on the relative areas of peaks detected under a particular chromatographic method. If the main peptide peak accounts for 99% of the relevant integrated chromatographic area, the sample may be reported as approximately 99% chromatographically pure.
That is useful information, but it does not automatically account for every material present in the vial.
Depending on the analytical method, substances such as water, counterions, certain residual solvents, inorganic material, or compounds that do not respond strongly to the detector may not be represented proportionally in that HPLC purity percentage.
This is why purity and peptide content are not identical concepts.
A lyophilized peptide sample may contain the target peptide along with water, acetate or trifluoroacetate counterions, residual solvents, or other components. A laboratory interested in total composition may therefore need additional analytical methods beyond the HPLC purity measurement.
Understanding HPLC
HPLC stands for high-performance liquid chromatography. Its basic job is separation.
A prepared sample is introduced into a flowing liquid called the mobile phase. That liquid carries the sample through a column containing another material called the stationary phase. Different molecules interact with the stationary phase to different degrees, so they move through the column at different speeds.
As components leave the column, a detector records their signal. The resulting graph is called a chromatogram.
The horizontal axis usually represents time, often referred to as retention time. The vertical axis represents detector response. Each resolved component appears as a peak.
For peptide work, reversed-phase HPLC is widely used. Peptides differ in their interactions with the hydrophobic stationary phase, allowing many related components to be separated.
A relatively clean sample may show one dominant main peak with several much smaller peaks around it. The chromatography software can calculate the area under each peak, which is often the basis of the reported chromatographic purity value.
Retention time provides another useful clue. If a known reference standard produces a major peak at a particular retention time under a defined method, a test sample can be compared against it. If the major peak from the sample behaves similarly, that supports identification.
But retention time alone is not absolute proof. Closely related molecules can sometimes behave similarly under the same chromatographic conditions.
This is where another important limitation appears: co-elution.
Co-elution occurs when two different components pass through the column so close together that they appear as one overlapping chromatographic peak. If a peptide impurity co-elutes with the target molecule, the chromatogram may appear cleaner than the sample really is.
This does not mean HPLC is unreliable. It means the quality of the method matters.
A strong analytical method should have enough resolving power to separate the peptide from the related impurities that are reasonably expected to be present.
Understanding Mass Spectrometry
Mass spectrometry approaches the sample from a different direction.
Instead of primarily asking how the molecules behave while passing through a chromatography column, a mass spectrometer measures ions according to their mass-to-charge ratio, usually written as m/z.
The peptide molecules are first ionized, meaning they are converted into charged particles. Those ions are then separated and detected according to their mass-to-charge characteristics.
For peptide identity testing, the measured mass can be compared with the theoretical mass expected from the peptide’s known amino acid sequence and chemical composition.
If the observed molecular mass closely matches the expected molecular mass, that provides powerful supporting evidence that the intended peptide is present.
Mass spectra can initially look confusing because a single peptide can produce more than one peak. One reason is that peptide molecules may carry different numbers of electrical charges. The same peptide may appear as a singly charged ion, doubly charged ion, triply charged ion, or other charge state.
These different peaks do not necessarily represent different contaminants. They may simply be different charged forms of the same molecule.
Software can mathematically combine those signals to estimate the peptide’s neutral molecular mass. This process is commonly called deconvolution.
Why MS/MS Goes Further
Basic mass spectrometry can provide excellent evidence of molecular mass, but researchers can learn even more by using tandem mass spectrometry, commonly written as MS/MS.
In MS/MS, a selected peptide ion is deliberately fragmented into smaller pieces. Those fragments are then measured.
Because peptides break apart in patterns related to their amino acid sequence, the resulting fragment masses can be compared with the fragments predicted from the expected peptide.
In simple terms, basic MS asks:
Does this molecule have the mass we expect?
MS/MS asks:
When we break the molecule into pieces, do those pieces support the structure or sequence we expect?
That makes MS/MS particularly valuable when deeper confirmation is required.
Why HPLC and Mass Spectrometry Work Well Together
HPLC and mass spectrometry are powerful precisely because they answer different questions.
HPLC tells us how the sample separates.
Mass spectrometry tells us what molecular masses are present.
MS/MS provides additional structural information.
When chromatography and mass spectrometry are combined in an LC-MS or LC-MS/MS system, a laboratory can first separate the components of a mixture and then obtain mass information about those components.
This can reveal peptide-related impurities that may be difficult to distinguish with HPLC-UV alone.
Where Peptide Impurities Come From
Peptide impurities do not necessarily mean that something foreign or visibly contaminated has entered the sample. Many peptide impurities are actually molecules that are closely related to the intended peptide.
A deletion impurity may be missing a single amino acid.
An insertion impurity may contain one additional amino acid.
A truncated peptide may have stopped growing before the full amino acid sequence was completed.
A misincorporated sequence may contain an incorrect amino acid.
Chemical degradation can create oxidized, deamidated, isomerized, or otherwise modified versions of the peptide.
Some peptides can form dimers, aggregates, or alternative structures.
The closer an impurity is to the intended peptide, the more demanding analytical separation can become.
Counterions and Moisture
Another concept beginners often encounter on a peptide COA is the counterion.
Peptides may be supplied as salts such as acetate or trifluoroacetate forms. These counterions can arise during synthesis and purification.
The sample can also contain residual moisture.
This matters because the physical mass of a lyophilized sample is not necessarily identical to the mass of active peptide molecule within that material.
For that reason, high-level reference-standard characterization can separately evaluate peptide content, water, counterions, residual solvents, and other material rather than assuming the HPLC purity percentage represents the entire vial.
Why Reference Standards Matter
Analytical science depends heavily on comparison. A reference standard is a highly characterized material used as a benchmark. A laboratory may compare a peptide sample against a reference standard during HPLC analysis, or use a reference material during quantitative testing. But this creates an important chain of trust. The reference material itself must first be characterized well enough to function as a meaningful benchmark. The analytical method must then be suitable for its intended purpose. Only after those pieces are established can the test result for the unknown sample be interpreted confidently.
That chain can be thought of as:
Well-characterized reference → suitable analytical method → test sample → analytical result → scientific interpretation
If one link is weak, confidence in the final conclusion can also weaken.
Putting It Into Practice
Imagine that a researcher receives a vial labeled Peptide X, 10 mg, accompanied by a COA reporting 99.1% HPLC purity and a mass spectrometry result stating “conforms.”
At first glance, the report seems reassuring. But a stronger review goes further.
The first step is to establish traceability. The lot or batch number on the vial should correspond to the lot number on the report. The peptide name and material description should agree. The test date should be available, and the testing laboratory should be identifiable.
If the COA cannot be clearly linked to the specific lot being studied, the analytical value of the document decreases immediately.
The next step is to interpret the purity result. A reported value of 99.1% is useful, but the researcher should ask what method produced that number. Was it reversed-phase HPLC? What type of detector was used? Was the chromatogram provided? Are small impurity peaks visible? Were relevant peaks integrated? Was a reference standard used?
These are not questions intended to undermine the result. They are questions that help explain what the result actually means.
The researcher can then examine the identity evidence.
If the mass spectrometry section reports both the expected molecular mass and the observed molecular mass, the reader can see the actual basis of the conclusion. A report that simply says “MS conforms” provides less information than a report that shows the spectrum and states the measured result.
The next question is what was not tested.
Perhaps the report contains HPLC purity and mass spectrometry only. That may still provide useful evidence, but it does not automatically answer questions about water, counterions, residual solvents, aggregation, endotoxin, microbial contamination, or other attributes.
Not every experiment needs every possible test. The important point is to distinguish what is known from what remains unmeasured.
Researchers should also look for agreement between the methods.
Suppose HPLC shows one dominant peak and mass spectrometry shows the expected molecular mass. Those two observations support one another.
Now imagine that mass spectrometry detects the expected peptide, but HPLC shows several substantial secondary peaks. The correct conclusion is not that mass spectrometry “proved the sample is pure.” The better conclusion is that mass spectrometry supports the presence of the intended peptide, while chromatography indicates that additional components are also present.
That distinction is the essence of analytical interpretation.
Good research practice also means preserving the evidence. The COA, chromatogram, mass spectrum, sample identifier, supplier information, and lot number should remain connected to the experimental record.
If an unusual result appears months later, the researcher can return to the exact analytical information associated with the material used.
This is one reason high-quality documentation matters almost as much as the original measurement.
Common Mistakes & Good Research Practice
One of the most common mistakes is treating 99% HPLC purity as meaning 99% of the entire vial is active peptide. HPLC purity is usually a chromatographic result based on what the method separates and detects. It is not automatically a complete mass-balance description of every substance present.
Another common mistake is using mass spectrometry as if it were automatically a purity measurement. Detecting the expected molecular mass provides strong identity evidence, but finding the correct peptide does not prove that nothing else is present.
The opposite mistake also occurs. A researcher may see one dominant HPLC peak and assume that the sample contains only one compound. Closely related impurities may co-elute, remain below the method’s detection capability, or require another analytical technique to reveal them.
Another error is focusing entirely on the appearance of the COA. A polished report with logos, signatures, and attractive graphics may look impressive, but visual presentation does not establish analytical quality. The meaningful questions are whether the sample is traceable, whether the analytical methods are appropriate, whether the data support the stated conclusions, and whether important limitations are acknowledged.
Researchers can also overlook the age and handling history of a sample. Analytical testing describes a material at a particular point in time. Peptides may change during storage, transportation, repeated handling, or exposure to unsuitable conditions. A strong original COA does not mean the material can never degrade.
Finally, researchers sometimes treat analytical testing as a simple pass-or-fail exercise. In reality, analytical results need context.
Modern analytical guidance emphasizes concepts such as specificity, selectivity, accuracy, precision, range, and robustness. Those terms all relate to one central question:
Can this method reliably answer the analytical question we are asking?
Good research practice therefore means understanding not only the result, but the method behind the result.
Key Takeaways
The most important lesson in peptide characterization is that no single analytical number tells the whole story.
Identity tells us whether the expected peptide is present.
Purity tells us how dominant the desired peptide appears relative to other detected chromatographic components under a particular method.
Assay or peptide content tells us how much of the desired peptide is actually present.
Impurity profiling attempts to determine what other peptide-related or process-related materials may exist.
A COA brings those pieces together, but the value of the COA depends entirely on the analytical work behind it.
HPLC is valuable because it separates components and creates a chromatographic picture of the sample.
Mass spectrometry is valuable because it provides molecular mass information.
MS/MS adds another level of structural evidence.
Additional analytical methods can answer questions that HPLC and mass spectrometry alone may not address.
The strongest confidence comes when different methods support the same conclusion from different scientific directions.
For a beginner, there is one question worth remembering whenever a laboratory result is presented:
What exactly did this test prove—and what did it not prove?
Learning to ask that question is one of the most useful steps toward becoming a better reader of peptide research.
Sources & Further Reading
International Council for Harmonisation — ICH Q2(R2): Validation of Analytical Procedures
Official guidance covering analytical procedure validation, including identity, assay, purity, impurity testing, specificity, accuracy, precision, and robustness.
https://database.ich.org/sites/default/files/ICH_Q2(R2)_Guideline_2023_1130.pdf
McCarthy D, Han Y, Carrick K, Schmidt D. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharmaceutical Research. 2023.
Detailed discussion of peptide reference standards, identity testing, HPLC, mass spectrometry, NMR, water, counterions, purity, and peptide-content determination.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10338602/
Mant CT, Chen Y, Yan Z, Popa TV, Kovacs JM, Mills JB, Tripet B, Hodges RS. HPLC Analysis and Purification of Peptides. Methods in Molecular Biology.
Comprehensive overview of peptide separation using HPLC, including reversed-phase chromatography and the principles underlying peptide separation.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7119934/
van den Broek I, Sparidans RW, Schellens JHM, Beijnen JH. Quantitative Bioanalysis of Peptides by Liquid Chromatography Coupled to Tandem Mass Spectrometry. Journal of Chromatography B. 2008.
Review covering LC-MS/MS analysis of peptides, sample preparation, chromatography, mass spectrometry, degradation, adsorption, and analytical validation.
https://pubmed.ncbi.nlm.nih.gov/18701357/
Zeng K, Geerlof-Vidavsky I, Gucinski A, Jiang X, Boyne MT. Liquid Chromatography–High Resolution Mass Spectrometry for Peptide Drug Quality Control.
FDA-associated research demonstrating how LC-high-resolution mass spectrometry can identify peptide-related impurities that may not always be adequately resolved using HPLC-UV alone.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4406950/
U.S. Food and Drug Administration — ANDAs for Certain Highly Purified Synthetic Peptide Drug Products
FDA guidance discussing peptide-related impurities, process-related impurities, and analytical considerations relevant to synthetic peptide quality.
https://www.fda.gov/media/107622/download
IN THIS ARTICLE
Table of Contents
Did You Know?
A peptide can look perfectly clean as a white or lyophilized powder and still contain related impurities, residual solvents, salts, or degradation products. Appearance alone is not a reliable measure of identity or purity.
Research Tip
Never treat a COA as the end of the conversation. Treat it as the start of verification. Good research practice means asking what was tested, how it was tested, what standard was used, and what the reported result actually means.
n peptide research, one of the first and most important questions is not what result you hope to see. It is much simpler than that: what exactly are you working with? A vial may arrive neatly labeled, professionally packaged, and accompanied by a Certificate of Analysis, yet none of those things by themselves guarantee that the material is correctly identified, highly pure, or suitable for a particular research purpose. Before a peptide ever enters an experiment, researchers need confidence that the material is what it claims to be and that the supporting analytical data are strong enough to support that claim.
This is where concepts such as identity, purity, reference standards, Certificates of Analysis (COAs), high-performance liquid chromatography (HPLC), and mass spectrometry (MS) become essential. In regulated analytical science, identity, purity, assay, and impurity testing are treated as distinct quality attributes, and analytical procedures are expected to be shown to be fit for their intended purpose. In other words, the goal is not simply to “have a test,” but to use a test that is appropriate, reliable, and informative for the question being asked.
For beginners, this topic can feel highly technical. The good news is that the core logic is straightforward. Researchers are trying to answer a sequence of practical questions. Is this the right peptide? How much of the sample is the desired peptide? What else may be present? How was that conclusion reached? And how much confidence should be placed in the document or data being presented? Once readers understand that logic, the jargon starts to make sense.
Free Download
Plan studies, organize raw data, track controls, analyze results, and document conclusions in one practical research workbook.
Want to Learn More?
Explore the SilverLeaf Learning Hub for more educational articles, peptide profiles, and research-focused resources.
